DRUG · COUNSELLING NOTES
Mogamulizumab
POTELIGEO
Updated
New prescription
indication: _____. IV infusion in clinic; report rash promptly; warned on allergies; serious/common AEs: infusion reaction, severe rash, infection; non-pharm: emollients, hand hygiene
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV infusion in clinic; report rash promptly; warned on allergies; serious/common AEs: infusion reaction, severe rash, infection; non-pharm: emollients, hand hygiene